Kristen Scholer sat down with Lloyd Blankfein, the CEO and Chairman of Goldman Sachs, to discuss the economy, his relationship with President Trump, and where the company stands on cryptocurrencies. Blankfein most recently saw President Trump in Davos and admitted that, even though he wasn't a supporter during the election, he agrees with Trump's message that promoting America's interests doesn't mean withdrawing from the world. Blankfein knows it may not be a popular opinion, but he says President Trump is good for small businesses and America's economy. Plus, Blankfein comments on Gary Cohn's place in The White House. He believes that Cohn, who previously served as Goldman's Chief Operating Officer, has accomplished everything he set out to do under the Trump administration. And don't expect Goldman to jump into the crypto craze anytime soon. Blankfein shot down rumors that the company will open a trading desk, saying that it will clear futures contracts for customers. He says there's a lot of "hype" over the digital assets and that he doesn't "love" the concept. Goldman is also focused more on digital distribution and turning around revenue numbers for its trading division. Blankfein discusses the company's "Marcus" division, which has issued $2 billion in consumer loans in the year after its launch in October 2016.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More